The company’s device is designed for accurate pedicle screw placement, but authorization from the FDA will allow the company to also commercialize its product for anterior approach instrumented spine surgery.
The filing represents SpineGuard’s first expanded application for its Threaded PediGuard outside of pedicle screw placement, Stéphane Bette, cofounder and deputy CEO of SpineGuard, said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
